Antibiotics have been around for less than a century. But as resistant bacteria become increasingly difficult to treat, we risk a greater number of deaths from infections.
Could a combination of phage therapy and antibiotics be the key to unlocking the antimicrobial-resistant superbug crisis?
Antibiotic-resistant bacteria causes 700,000 deaths annually, but there are strategies we can use to slow the rapid rise of these superbugs.
Professor Dena Lyras’ continuing mission lies in trying to understand the formidable enemy of antibiotic-resistant bacteria, particularly those in the human gut.
Using phage therapy to resensitise a type of bacteria to antibiotics, researchers have found a way to revert antibiotic resistance.
Nursing homes are coming under the spotlight in the ongoing antimicrobial resistance war.
Associate Professor John Boyce is part of an international team about to begin a new five-year investigation into the superbug, its antibiotic-resistance mechanisms, and also novel (new) treatments for infection.
Despite dire warnings of a looming antibiotic resistance crisis, the issue has failed to capture the public imagination.
More than 2000 cases and 170 deaths have been recorded in Madagascar in the past three months.
Dummy text